| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein-glutamic acid ligase activity | 6.73e-05 | 10 | 25 | 2 | GO:0070739 | |
| GeneOntologyMolecularFunction | tubulin-glutamic acid ligase activity | 6.73e-05 | 10 | 25 | 2 | GO:0070740 | |
| GeneOntologyMolecularFunction | acid-amino acid ligase activity | 3.75e-04 | 23 | 25 | 2 | GO:0016881 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-nitrogen bonds | 1.99e-03 | 53 | 25 | 2 | GO:0016879 | |
| Domain | TLDc_dom | 1.63e-05 | 6 | 20 | 2 | IPR006571 | |
| Domain | TLD | 1.63e-05 | 6 | 20 | 2 | PF07534 | |
| Domain | TTL | 8.44e-05 | 13 | 20 | 2 | PS51221 | |
| Domain | TTL/TTLL_fam | 8.44e-05 | 13 | 20 | 2 | IPR004344 | |
| Domain | TTL | 8.44e-05 | 13 | 20 | 2 | PF03133 | |
| Domain | ATP_grasp_subdomain_2 | 4.97e-04 | 31 | 20 | 2 | IPR013816 | |
| Domain | - | 7.10e-03 | 119 | 20 | 2 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 7.10e-03 | 119 | 20 | 2 | IPR029058 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 2.30e-04 | 27 | 12 | 2 | MM15549 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 6.73e-04 | 46 | 12 | 2 | M27828 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 12009310 | ||
| Pubmed | A targeted multienzyme mechanism for selective microtubule polyglutamylation. | 3.85e-05 | 13 | 25 | 2 | 17499049 | |
| Pubmed | Tubulin polyglutamylase enzymes are members of the TTL domain protein family. | 4.49e-05 | 14 | 25 | 2 | 15890843 | |
| Pubmed | Klf4 glutamylation is required for cell reprogramming and early embryonic development in mice. | 1.47e-04 | 25 | 25 | 2 | 29593216 | |
| Pubmed | 4.00e-04 | 41 | 25 | 2 | 19343720 | ||
| Cytoband | 1p31.1 | 6.91e-04 | 71 | 25 | 2 | 1p31.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p31 | 6.60e-03 | 224 | 25 | 2 | chr1p31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20q11 | 8.03e-03 | 248 | 25 | 2 | chr20q11 | |
| GeneFamily | Tubulin tyrosine ligase family | 3.66e-05 | 14 | 12 | 2 | 779 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN | 8.84e-07 | 198 | 24 | 5 | M4264 | |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP | 1.22e-05 | 339 | 24 | 5 | M34012 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN | 2.81e-05 | 195 | 24 | 4 | M4279 | |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN | 2.81e-05 | 195 | 24 | 4 | M4292 | |
| Coexpression | GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_UP | 2.87e-05 | 196 | 24 | 4 | M41141 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN | 3.10e-05 | 200 | 24 | 4 | M7595 | |
| Coexpression | BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE | 4.90e-05 | 78 | 24 | 3 | M2532 | |
| Coexpression | HALLMARK_INTERFERON_ALPHA_RESPONSE | 9.40e-05 | 97 | 24 | 3 | M5911 | |
| Coexpression | GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_UP | 1.34e-04 | 292 | 24 | 4 | M41140 | |
| Coexpression | ERWIN_COHEN_BLOOD_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_UP | 1.72e-04 | 119 | 24 | 3 | M41139 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP | 1.95e-04 | 973 | 24 | 6 | M41080 | |
| Coexpression | FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_POSITIVE | 2.19e-04 | 129 | 24 | 3 | M41110 | |
| Coexpression | GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 4.58e-04 | 166 | 24 | 3 | M9100 | |
| Coexpression | GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP | 4.99e-04 | 171 | 24 | 3 | M5655 | |
| Coexpression | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP | 6.08e-04 | 183 | 24 | 3 | M6670 | |
| Coexpression | TRAYNOR_RETT_SYNDROM_UP | 6.14e-04 | 40 | 24 | 2 | M2712 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP | 6.18e-04 | 184 | 24 | 3 | M8544 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP | 6.58e-04 | 188 | 24 | 3 | MM983 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN | 6.68e-04 | 189 | 24 | 3 | M4261 | |
| Coexpression | GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_DN | 6.78e-04 | 190 | 24 | 3 | M384 | |
| Coexpression | GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN | 6.89e-04 | 191 | 24 | 3 | M4715 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN | 6.99e-04 | 192 | 24 | 3 | M4277 | |
| Coexpression | GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN | 7.21e-04 | 194 | 24 | 3 | M6082 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN | 7.42e-04 | 196 | 24 | 3 | M4267 | |
| Coexpression | GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_DN | 7.42e-04 | 196 | 24 | 3 | M9590 | |
| Coexpression | GSE2706_2H_VS_8H_R848_STIM_DC_DN | 7.42e-04 | 196 | 24 | 3 | M4730 | |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN | 7.53e-04 | 197 | 24 | 3 | M4294 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP | 7.53e-04 | 197 | 24 | 3 | M7543 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN | 7.64e-04 | 198 | 24 | 3 | M4272 | |
| Coexpression | GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN | 7.64e-04 | 198 | 24 | 3 | M3302 | |
| Coexpression | GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN | 7.64e-04 | 198 | 24 | 3 | M8969 | |
| Coexpression | GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN | 7.76e-04 | 199 | 24 | 3 | M3311 | |
| Coexpression | GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP | 7.76e-04 | 199 | 24 | 3 | M9306 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN | 7.76e-04 | 199 | 24 | 3 | M8971 | |
| Coexpression | GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_UP | 7.76e-04 | 199 | 24 | 3 | M7655 | |
| Coexpression | GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN | 7.76e-04 | 199 | 24 | 3 | M3669 | |
| Coexpression | GSE27786_LSK_VS_CD8_TCELL_UP | 7.76e-04 | 199 | 24 | 3 | M4749 | |
| Coexpression | GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP | 7.87e-04 | 200 | 24 | 3 | M8554 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_DN | 7.87e-04 | 200 | 24 | 3 | M9408 | |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP | 7.87e-04 | 200 | 24 | 3 | M9458 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN | 7.87e-04 | 200 | 24 | 3 | M4269 | |
| Coexpression | GSE3982_NKCELL_VS_TH2_DN | 7.87e-04 | 200 | 24 | 3 | M5598 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP | 7.87e-04 | 200 | 24 | 3 | M7324 | |
| Coexpression | GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN | 7.87e-04 | 200 | 24 | 3 | M3288 | |
| Coexpression | GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN | 7.87e-04 | 200 | 24 | 3 | M3279 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN | 7.87e-04 | 200 | 24 | 3 | M8967 | |
| Coexpression | GSE10325_MYELOID_VS_LUPUS_MYELOID_DN | 7.87e-04 | 200 | 24 | 3 | M3097 | |
| Coexpression | HALLMARK_ESTROGEN_RESPONSE_EARLY | 7.87e-04 | 200 | 24 | 3 | M5906 | |
| Coexpression | GSE42021_TREG_VS_TCONV_PLN_UP | 7.87e-04 | 200 | 24 | 3 | M9572 | |
| Coexpression | GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN | 7.87e-04 | 200 | 24 | 3 | M9570 | |
| Coexpression | BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP | 8.33e-04 | 204 | 24 | 3 | M34006 | |
| Coexpression | DAUER_STAT3_TARGETS_DN | 8.83e-04 | 48 | 24 | 2 | M13696 | |
| Coexpression | BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP | 9.19e-04 | 211 | 24 | 3 | M2230 | |
| Coexpression | GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP | 9.58e-04 | 50 | 24 | 2 | M6117 | |
| Coexpression | GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_60DY_UP | 9.58e-04 | 50 | 24 | 2 | M40985 | |
| Coexpression | GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_UP | 1.02e-03 | 219 | 24 | 3 | M41142 | |
| Coexpression | HOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | 1.19e-03 | 231 | 24 | 3 | M40995 | |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP | 1.41e-03 | 545 | 24 | 4 | M34016 | |
| ToppCell | Mild-CD4+_T_activated|World / Disease group and Cell class | 7.38e-08 | 196 | 25 | 5 | 417b4fc2e4388f34c410576131b02936f93e46b6 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.98e-06 | 163 | 25 | 4 | 00e791358a7eb6c3e95f87afe22153845012e4a1 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.34e-06 | 170 | 25 | 4 | 07b561cd9c528bc8444c9385e1de621eee7b697e | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.87e-06 | 179 | 25 | 4 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.13e-06 | 183 | 25 | 4 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.49e-06 | 188 | 25 | 4 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.71e-06 | 191 | 25 | 4 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | Mild/Remission-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.71e-06 | 191 | 25 | 4 | 382686d62f7b8576c44bb9726a4e10dc26fd348e | |
| ToppCell | ILEUM-inflamed-(6)_ILC3|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.03e-06 | 195 | 25 | 4 | c6968da7d2b60c2163e1ff0ffa41340e1ec1d2ed | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 4.11e-06 | 196 | 25 | 4 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | Mild-CD8+_T_activated|Mild / Disease group and Cell class | 4.28e-06 | 198 | 25 | 4 | ceac1b51bacfd0dd7fe7c6a666f7927055e1f380 | |
| ToppCell | VE-CD4-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster | 4.37e-06 | 199 | 25 | 4 | 056a0538ca5e825ae6195b4c76c208708a014533 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.92e-05 | 150 | 25 | 3 | 322aa0c3fc159a4b2897daac881dfc744b24ffc4 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Monocyte-derived_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.39e-05 | 153 | 25 | 3 | 859de35b24c5d7d73be1c213b90b43362ee2e0eb | |
| ToppCell | PBMC-Control-cDC_1|Control / Compartment, Disease Groups and Clusters | 8.89e-05 | 156 | 25 | 3 | 9b6c5bcac516a62bcc1f5be32ffa8c92735ef0bc | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.41e-05 | 159 | 25 | 3 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.01e-04 | 163 | 25 | 3 | d005115aa1e1458b51de7eb719794617a4168608 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-red_blood_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 165 | 25 | 3 | 62dd54dfbec7f43a41546a1fec719545c2608a36 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 169 | 25 | 3 | d4a0bd792bddfa34332d7dc432ce253f50d98c6f | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.15e-04 | 170 | 25 | 3 | 070d8683d1a5cc7d594ff0453c961a9bf982c2d0 | |
| ToppCell | Severe-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.17e-04 | 171 | 25 | 3 | 61205a4986c2d0a89aea96ed8dec9e952eeb6ff1 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-04 | 174 | 25 | 3 | e70cc623a3a6aceec813ed852fec0c4240561133 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-04 | 174 | 25 | 3 | b6725086fe5a2b057c7c495ec63c970ac52c2580 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-04 | 174 | 25 | 3 | 9bb8159a62640756d18ecbade3bf32bcbb7dd590 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.25e-04 | 175 | 25 | 3 | 87e557f7508c88b2087db5d57e77d5e2c92ca083 | |
| ToppCell | COVID-19-kidney-CD-IC-A|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.27e-04 | 176 | 25 | 3 | 45028197364c64e93e3ffe86aff773d47a477d49 | |
| ToppCell | BAL-Control-cDC_1|Control / Compartment, Disease Groups and Clusters | 1.29e-04 | 177 | 25 | 3 | aa021f6d62e9d740c5ea499faaf875de835a2865 | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-04 | 177 | 25 | 3 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 1.29e-04 | 177 | 25 | 3 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 1.31e-04 | 178 | 25 | 3 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 179 | 25 | 3 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 181 | 25 | 3 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.40e-04 | 182 | 25 | 3 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.40e-04 | 182 | 25 | 3 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.40e-04 | 182 | 25 | 3 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.40e-04 | 182 | 25 | 3 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | Mild-CD4+_T|World / Disease group and Cell class | 1.43e-04 | 183 | 25 | 3 | c4ac8893d38a3da4e19fe2ef1756bd69c89e975c | |
| ToppCell | COVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type | 1.43e-04 | 183 | 25 | 3 | 5c7597a5b2bf6a481ca2c7e68560179214150fa0 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.43e-04 | 183 | 25 | 3 | 7717fce227b4e02ed41baad8ae7dd2e22bd7c13e | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 186 | 25 | 3 | f5468e03321ea2083e223eb0d92c3a9307039569 | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.52e-04 | 187 | 25 | 3 | 72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 187 | 25 | 3 | 16e55d802fc4e71878305e61ad03806aabd59537 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.52e-04 | 187 | 25 | 3 | 39b99f46b723f7f3c44880d7fe8642cbad558b8a | |
| ToppCell | ILEUM-non-inflamed-(6)_ILC3|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.62e-04 | 191 | 25 | 3 | 6eaf72b41084404bee0db04e4605db745a74995f | |
| ToppCell | moderate-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.67e-04 | 193 | 25 | 3 | 22455801194bd8c73c5c397f5eac4f723429c383 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.67e-04 | 193 | 25 | 3 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | Mild_COVID-19|World / Disease group,lineage and cell class （2021.01.30） | 1.67e-04 | 193 | 25 | 3 | 325b0768827bf8701bfb7f686bb11fd8b1a41a5c | |
| ToppCell | Mild/Remission-B_activate-7|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.69e-04 | 194 | 25 | 3 | 01c97543972159a9468272da06e7e611e2c21fae | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 1.72e-04 | 195 | 25 | 3 | 1992a1673b7213e25f3c76ac77da35c57daceddd | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.72e-04 | 195 | 25 | 3 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_4|COVID-19_Severe / Disease condition and Cell class | 1.72e-04 | 195 | 25 | 3 | 787ea9f38ad8e2a836222ca97f4d927f7e79517d | |
| ToppCell | BAL-Mild|BAL / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.74e-04 | 196 | 25 | 3 | 6566e6671257f7df4d3f375e84f0b292ab4bcde1 | |
| ToppCell | BAL-Mild|BAL / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.74e-04 | 196 | 25 | 3 | 3408d561d29802fca9eff5c54ccf70818d240cea | |
| ToppCell | CV-Moderate-1|Moderate / Virus stimulation, Condition and Cluster | 1.74e-04 | 196 | 25 | 3 | b50cfcd87c5b67806450cb8b3c6860ab97f6d3b1 | |
| ToppCell | Mild-CD4+_T_activated|Mild / Disease group and Cell class | 1.74e-04 | 196 | 25 | 3 | daa1c3322d81e649161e889e1d78451d2d425d09 | |
| ToppCell | CV-Moderate-1|CV / Virus stimulation, Condition and Cluster | 1.77e-04 | 197 | 25 | 3 | e3d00d850b4d191f9592ef993c0eaadfe5710b5f | |
| ToppCell | Severe_COVID-19|World / Disease group,lineage and cell class （2021.01.30） | 1.80e-04 | 198 | 25 | 3 | 09fd456077bb3a657ad3b10c6cfe799b7266456a | |
| ToppCell | CV-Mild-1|CV / Virus stimulation, Condition and Cluster | 1.80e-04 | 198 | 25 | 3 | 4b078714c49e7befb7b113d72485e712236d35fa | |
| ToppCell | BAL-Severe|BAL / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.80e-04 | 198 | 25 | 3 | 454aee3f4fe6d0beeccc55200b4495f4f9b44feb | |
| ToppCell | BAL-Severe|BAL / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.80e-04 | 198 | 25 | 3 | 687f69c16343227854c882b4a0f3930ce534a3d2 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-MAIT|URO / Disease, condition lineage and cell class | 1.80e-04 | 198 | 25 | 3 | 75db638278d4be2b0f406cd8871058a8352c5a86 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 1.80e-04 | 198 | 25 | 3 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | ILEUM-inflamed-(6)_ILC-(6)_ILC3|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.82e-04 | 199 | 25 | 3 | 02879df850b0c72b57d7b22cfc43f3407e182dcb | |
| ToppCell | ILEUM-non-inflamed-(6)_ILC-(6)_ILC3|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.82e-04 | 199 | 25 | 3 | ba144739f65560207303c0143e8de1e86922bebb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.82e-04 | 199 | 25 | 3 | e245851a5bddf56f7e13a7fb7c5fda2fd275dae3 | |
| ToppCell | Sigmoid-(3)_ILC|Sigmoid / shred on region, Cell_type, and subtype | 1.85e-04 | 200 | 25 | 3 | a7326c43987a5eb4f4f5b48c4252cf4870432e5d | |
| ToppCell | Sigmoid-(3)_ILC-(30)_ILC|Sigmoid / shred on region, Cell_type, and subtype | 1.85e-04 | 200 | 25 | 3 | c39de94623383da7b2b260eb016ddaa5da7f4350 | |
| ToppCell | Sigmoid-ILC-ILC|Sigmoid / Region, Cell class and subclass | 1.85e-04 | 200 | 25 | 3 | 4ac1e6d7f358003e2448eb69e545772cd261c55f | |
| ToppCell | Sigmoid-ILC|Sigmoid / Region, Cell class and subclass | 1.85e-04 | 200 | 25 | 3 | dfb06821f1019833f5d81f9c93808219b5fef407 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 1.85e-04 | 200 | 25 | 3 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.85e-04 | 200 | 25 | 3 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.86e-04 | 52 | 25 | 2 | d654e2b77c53ed5319015598b68a20bf4416380c | |
| ToppCell | Bronchus_Control_(B.)-Endothelial-TX-Endothelial-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 9.35e-04 | 81 | 25 | 2 | a1193b2cfb84a6b6593779fef5f54a61567a12d7 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.97e-03 | 118 | 25 | 2 | f76fc6db7368a1e8e5e4f8535fc3dc78afe13b9b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.97e-03 | 118 | 25 | 2 | 0dcac16eea8e7978de370a815da9a0cdd212598e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.97e-03 | 118 | 25 | 2 | 7da3957d102e9f9825fc2609d6d0bd9ca6a3fba4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.97e-03 | 118 | 25 | 2 | c5c6724e0e526d7c2fc8cabff4a112a900ec997f | |
| ToppCell | Control-Lymphoid_T/NK-CD4+_T_activated|Control / Disease group, lineage and cell class | 2.00e-03 | 119 | 25 | 2 | d7352d0dafbb664619b7a1e3cd07b159fdfec197 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-03 | 123 | 25 | 2 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-03 | 125 | 25 | 2 | 5626eb77e542fcc87cd1fdf65f8623f3249ff9db | |
| ToppCell | control-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.31e-03 | 128 | 25 | 2 | 24abab941b4a2f89e13089d208d40ec02f0cad10 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.34e-03 | 129 | 25 | 2 | 5e4783cc63afdeaebdfaecb72f95f3efc8d3c4a3 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.38e-03 | 130 | 25 | 2 | 6c6a8b77af08b30b424d4f5def37315d3c6e28b2 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_fibroblast-mesenchymal_B|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.38e-03 | 130 | 25 | 2 | 0706092f6b466585b3b4808b3b982a122d66cfcf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-03 | 133 | 25 | 2 | f303ab771482281d8793974f9f5279cee09431fe | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-pDC|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.56e-03 | 135 | 25 | 2 | 0afe232aa1a1e6c37a5b3183b67d7fa07e0ea791 | |
| ToppCell | CTRL-Lymphoid-pDC|CTRL / Disease state, Lineage and Cell class | 2.71e-03 | 139 | 25 | 2 | bbc10812b0c5b8c85e78171c12316becde8895c3 | |
| ToppCell | Healthy-CD4+_T_activated|World / disease group, cell group and cell class | 2.75e-03 | 140 | 25 | 2 | 407691970ec72a3afb45e431cf48814546b8acff | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-03 | 140 | 25 | 2 | e64f6aa57bc069cfe970089bd1c298433bfaf771 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.79e-03 | 141 | 25 | 2 | cabb5b8c0874813c713508af2ac620ab0d61ab6f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.79e-03 | 141 | 25 | 2 | 3fa3d2a8ebd9c285168ecea6db9cad74d3a3e85a | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.83e-03 | 142 | 25 | 2 | 1eecbec805a873fa3539df0574670cf73c18c7b1 | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-03 | 143 | 25 | 2 | bb8d4c335682d1a6798bed0de8bb0603054a4944 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.91e-03 | 144 | 25 | 2 | 1b9e95e4f6e40042d3cf2f94c067f3a6b19428ea | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-03 | 144 | 25 | 2 | cc11cce43d1af8ac63140d05faf215ae9a10cde1 | |
| ToppCell | Control-Myeloid-Dendritic_cells-pDC|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.95e-03 | 145 | 25 | 2 | bab85a72142b6257f7d424e5301f65b6dcdf745d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-03 | 145 | 25 | 2 | fd02d55755c35288a42ab08a82450b370aad35a7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-03 | 145 | 25 | 2 | 9964d6d3769be2f35d86268fe044cecd1d5a1616 | |
| ToppCell | Healthy-CD4+_T_activated|Healthy / disease group, cell group and cell class | 2.95e-03 | 145 | 25 | 2 | 45e8089fdf7d6f69b383816d8945e39fba24c873 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-03 | 145 | 25 | 2 | bfa196ac1db7acbfcbb2ba9f137036a95e16e091 | |
| Disease | apolipoprotein A 1 measurement | 6.38e-04 | 848 | 25 | 5 | EFO_0004614 | |
| Disease | proliferative diabetic retinopathy | 1.22e-03 | 61 | 25 | 2 | EFO_0009322 | |
| Disease | velopharyngeal dysfunction | 4.78e-03 | 122 | 25 | 2 | EFO_0009336 | |
| Disease | serum metabolite measurement | 7.73e-03 | 945 | 25 | 4 | EFO_0005653 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LWVKIDLTLLSRIPE | 766 | P51826 | |
| LELDGTLVKIWLLVP | 46 | Q8N0U6 | |
| WDLLLFLLRELVEKG | 1151 | Q8IWY9 | |
| LLDKWNLIPEGIDIL | 196 | Q15777 | |
| DELWKGRLLPLVLLA | 181 | Q9H1C0 | |
| KVPLLLSILGAILWV | 176 | A0A0K2S4Q6 | |
| VVPSLLELAWEKLLA | 401 | Q6PID8 | |
| SLPAFLKLWIELLII | 126 | Q01650 | |
| SLPAFLKLWIELLII | 126 | Q9GIP4 | |
| ILLLLLEVTLAGWEP | 16 | Q9Y5E8 | |
| PWVEVLVEILLALLA | 646 | Q9BQG0 | |
| LVLVLDKDLQKLPWE | 1891 | Q14674 | |
| WELDPVKDVLILSAL | 396 | Q8TCB0 | |
| AEVLKTPLDLVRLWL | 2671 | Q9UFH2 | |
| TELDILKLWILTKLP | 216 | Q5VWZ2 | |
| WKPALVVLTEKDLLI | 341 | Q13884 | |
| TLIELLLPKLEEWKA | 226 | P52630 | |
| LWLLKRIQVPIEDIL | 631 | Q8NI08 | |
| LLLDLTWLEKLLPKT | 551 | P03915 | |
| KELWDVLLLPELDAV | 656 | Q75T13 | |
| LAEKLIGVLFEVWLL | 191 | Q86X10 | |
| DILIDQDLKPWLLEV | 326 | Q3SXZ7 | |
| LGLLLKVLLDWPVEV | 121 | Q9BY10 | |
| LLEKQRWPEVLLLLT | 391 | O15050 | |
| DILLDRKLKPWLLEI | 336 | Q6ZT98 | |
| DPLLLLTWKTVIGLL | 376 | Q8N1T3 |